Open-source APIs and a developer community for FDA data
OpenFDA Now Allows Direct Downloads of Data
Since its launch in June 2014, the impetus for openFDA has been to make it easier to get access to publicly available FDA data. FDA’s goal is to make it simple for an application, mobile device, web developer, or researcher to use data from FDA. .
…OpenFDA Team December 22, 2015
OpenFDA Unveils Cache of Medical Device Data
OpenFDA is releasing information on medical devices that could spur innovation and advance scientific research.
OpenFDA’s Application Programming Interface (API) expands the previous openFDA resources about medical device-related adverse events …
Taha Kass-Hout, MD, MS, Roselie A. Bright, ScD, MS, Ann Ferriter August 30, 2015
Mark your calendars: A new release coming soon from openFDA
The FDA created openFDA to make their public information about food, drugs, and devices more accessible and useful to developers. To that end, the FDA has made a continuous effort to better understand the needs of the developer community and build on e…
OpenFDA Team August 5, 2015
OpenFDA: Drilling Into The Details
By design, openFDA is an open system. It is built using open standards, uses open source software, and the code itself is publicly available at Github. Given the unique nature of this approach, the technical details of this system may be of interest…
OpenFDA Team July 22, 2015
OpenFDA: The First Year in Perspective
On May 22, 2015, Dr. Taha Kass-Hout gave an update on the openFDA project at the Big Data in Biomedicine conference at Stanford University.
His talk, coming a year after the first APIs were launched at openFDA, covers the progress that…
Taha Kass-Hout, MD, MS July 19, 2015
Announcing the OpenFDA Developer Challenge - An open call to tap public data and improve public health
The FDA is launching its very first openFDA challenge to the developer community to take advantage of the following datasets and explore the range and extent of its impact for research.
-
Adverse events data. FDA’s publi…
Taha Kass-Hout, MD, MS May 10, 2015
-
Providing easy access to medical device reports submitted to FDA since the early 1990s
In addition to food and drugs, FDA has regulatory oversight of tens of thousands of medical devices ranging from bandages and prosthetics to heart valves and robotics. These products are used by millions of Americans, and they are essential, well-perfo…
Taha Kass-Hout, MD, MS, Jeffrey Shuren, MD, JD August 18, 2014
Providing easy public access to prescription drug, over-the-counter drug, and biological product labeling
Every prescription drug (including biological drug products) approved by FDA for human use comes with FDA-approved labeling. The labeling contains information necessary to inform healthcare providers about the safe and effective use of the drug for it…
Taha Kass-Hout, MD, MS August 17, 2014
OpenFDA provides ready access to recall data
Every year, hundreds of human and animal foods, drugs, and medical devices are recalled from the market by manufacturers. These products may be labeled incorrectly or might pose health or safety issues. Most recalls are voluntary; in some cases they ma…
Taha Kass-Hout, MD, MS August 7, 2014
Introducing openFDA
Welcome to the new home of openFDA! We are incredibly excited to see so much interest in our work and hope that this site can be a valuable resource to those wishing to use public FDA data in both the public and private sector to spur innovation, furt…
Taha Kass-Hout, MD, MS June 2, 2014
OpenFDA: Innovative initiative opens door to wealth of FDA’s publicly available data
Today, I am pleased to announce the launch of openFDA, a new initiative from our Office of Informatics and Technology Innovation (OITI). OpenFDA is specifically designed to make it easier for developers, researchers,…
Taha Kass-Hout, MD, MS June 1, 2014
Ten things to know about drug adverse events
We’re incredibly excited by today’s launch of openFDA, and in particular around the first publicly available dataset that has been published, FDA’s drug adverse reaction and medication error reports. The dataset is huge, cove…
Sean Herron June 1, 2014
FDA’s path forward for open data and Next Generation Sequencing
FDA has established an Office of Informatics and Technology Innovation (OITI) under the Chief Health Informatics Officer (CHIO) in order to spur technology innovation. The following presentation highlight two exciting initiatives within OITI:
Taha Kass-Hout, MD, MS March 5, 2014